BioWorld MedTech

Nov. 3, 2011

Mela Sciences secures PMA for MelaFind after lengthy delays

Mela Sciences (Irvington, New York) reported that it has received a PMA for its MelaFind skin cancer detection device, after intense discussion with the FDA regarding the device throughout the past few years. Read More

VitroStealth shows potential as a coating for biosensors

International report: CoreValve system used for first time in Japanese clinical trial

Washington roundup: CMS announces 27% pay cut for Part B doc fees in FY '12

Financings roundup: Echo says warrant deal offers financial flexibility

Patent watch: Biomoda files application for CyPath refinement tool

Late-Breaking FDA valve stent approvals: Edwards gets FDA approval for Sapien transcather valve

FDA approves TriVascular's 20-mm Ovation stent system

NASS Notebook: Orthofix launches Collage bone graft substitute at NASS

Court report: MRI Associates awarded $52M in damages in case

HIT roundup: Trend renews membership with MDISS consortium

Agreements/contracts: Welch Allyn to provide EHR services to organizations

Deals roundup: Salmat's management buyout of VeCommerce is complete

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

New mechanism of action identified for QC-6352

BioWorld Science

QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...